Skip to main content
Fig. 4 | EJNMMI Research

Fig. 4

From: Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft

Fig. 4

PET images of [18F]FLT (horizontal sections) at 110–120 min postinjection in the mice bearing the tumor. a Control group. b Sorafenib-treated group. Filled arrows show the tumor region and blank arrows show the bladder. Artifacts due to extremely high radioactivity accumulation were observed in the bladder area. c SUVs of [18F]FLT in the tumor at 110–120 min postinjection

Back to article page